ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 149 out of 890

$815K Total Retail Price of All Prescriptions

Rank: 96 out of 890

464 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,068 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 389 368 1 2
OMEPRAZOLE 342 318 2 8
AMLODIPINE BESYLATE 301 284 3 1
NAMENDA 294 294 4 36
FUROSEMIDE 286 284 5 7
DONEPEZIL HCL 275 269 6 30
METOPROLOL TARTRATE 251 239 7 15
SIMVASTATIN 239 211 8 5
METFORMIN HCL 231 210 9 6
WARFARIN SODIUM 216 216 10 24
MELOXICAM 210 160 11 18
TRAMADOL HCL 198 173 12 16
HYDROCODONE-ACETAMINOPHEN 193 146 S3 13 3
LISINOPRIL 184 152 14 4
ZOLPIDEM TARTRATE 182 143 15 19
POLYETHYLENE GLYCOL 3350 174 166 16 67
POTASSIUM CHLORIDE 163 157 17 11
SERTRALINE HCL 162 157 18 26
AZITHROMYCIN 159 126 19 37
PANTOPRAZOLE SODIUM 155 137 20 34
ATORVASTATIN CALCIUM 152 140 21 13
ESCITALOPRAM OXALATE 143 128 22 51
DIOVAN 142 129 23 33
EXELON 134 134 24 113
LANTUS 129 107 25 50
QUETIAPINE FUMARATE 129 116 25 73
METOPROLOL SUCCINATE 125 113 27 17
CITALOPRAM HBR 116 111 28 20
MEGESTROL ACETATE 114 113 R 29 92
CYMBALTA 113 94 30 45
GABAPENTIN 108 79 31 12
CIPROFLOXACIN HCL 102 91 32 58
FENOFIBRATE 98 92 33 74
PREDNISONE 96 81 34 47
TAMSULOSIN HCL 96 91 34 32
CLOPIDOGREL 96 91 34 28
ADVAIR DISKUS 89 78 37 52
HYDROCHLOROTHIAZIDE 83 65 38 9
CARVEDILOL 82 71 39 22
CLONIDINE HCL 81 50 40 35
RISPERIDONE 78 78 41 78
NOVOLOG 78 64 41 178
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 58 43 76
MIRTAZAPINE 75 71 44 82
GLIMEPIRIDE 70 70 45 27
PRAVASTATIN SODIUM 67 56 46 10
LOVASTATIN 65 65 47 46
LUNESTA 64 64 48 283
LEVOFLOXACIN 64 55 48 107
NOVOLIN R 63 59 50 153
SPIRIVA 62 60 51 66
HYDRALAZINE HCL 62 50 51 100
ALBUTEROL SULFATE 62 62 51 162
TRAZODONE HCL 61 56 54 40
LOSARTAN-HYDROCHLOROTHIAZIDE 60 59 55 57
SEROQUEL 59 56 56 167
PROAIR HFA 58 33 57 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 26 58 21
LOVAZA 56 43 58 120
ATENOLOL 56 39 58 23
LOSARTAN POTASSIUM 55 55 61 29
CLOTRIMAZOLE-BETAMETHASONE 54 54 62 152
NEXIUM 53 41 63 14
BUSPIRONE HCL 53 46 63 133
FLUTICASONE PROPIONATE 52 43 65 39
MUPIROCIN 51 44 66 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.